ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Dermatology · Clin Exp Dermatol · 2026-09-25

Meta-analysis of 3 RCTs (643 patients with rosacea): minocycline 40 mg extended-release (DFD-29) increased IGA treatment success vs modified-release doxycycline (OR 2.51; 95% CI 1.80-3.49) and reduced lesion counts more, with no difference in adverse events.

Meta-analysisn = 643
Ghanem et al. Efficacy and safety of oral minocycline hydrochloride 40 mg extended-release capsules (DFD-29) versus doxycycline in rosacea: a systematic review and meta-analysis

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.